Development of New Anthrax Vaccine Underway With HHS Support

A new anthrax vaccine that could be easier and faster to produce than the existing licensed product will undergo initial clinical studies through an agreement between the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) and Pfenex, Inc. of San Diego.
Source: PHPartners.org - Category: Global & Universal Source Type: news